Filing Details
- Accession Number:
- 0001209191-19-009630
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-13 16:27:54
- Reporting Period:
- 2019-02-11
- Accepted Time:
- 2019-02-13 16:27:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1446372 | M Paul Silva | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp & Interim Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-02-11 | 1,400 | $179.35 | 23,386 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-11 | 2,100 | $180.38 | 21,286 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-11 | 715 | $181.09 | 20,571 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 169 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $179.35 (range $178.75 to $179.64).
- Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $180.38 (range $179.78 to $180.76).
- Open market sales reported on this line occurred at a weighted average price of $181.09 (range $180.88 to $181.36).